NHIC vs HIVE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 15, 2026

NHIC

63.3
AI Score
VS
NHIC Wins

HIVE

54.4
AI Score

Investment Advisor Scores

NHIC

63score
Recommendation
BUY

HIVE

54score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric NHIC HIVE Winner
Net Income -2.64M -148.45M NHIC
ROE 19.8% -28.0% NHIC
ROA -1.2% -23.2% NHIC
Total Assets 213.47M 639.15M HIVE
Cash 364,000 23.11M HIVE
Current Ratio 0.08 1.10 HIVE

Relative Price Performance (Last 90 Days)

NHIC 1M: -1.7% · 3M: +2.5% HIVE 1M: -4.7% · 3M: -21.3%

Current Technical Phase

NHIC

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -0.9%) with fading momentum, RSI 40

RSI (14): 40.4 · Price: $10.62

HIVE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 52

RSI (14): 51.9 · Price: $3.03

Fundamentals Snapshot

Metric NHIC HIVE
Market Cap
Forward P/E 0.0 -5.9
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.7%
Gross Margin 0.4%
Operating Margin 0.0% -0.6%
EPS 0.00 -1.54
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, NHIC is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.